rs558341655
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM2PM5PP3_ModeratePP5_Very_Strong
The NM_176787.5(PIGN):c.283C>T(p.Arg95Trp) variant causes a missense change. The variant allele was found at a frequency of 0.0000192 in 1,460,066 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R95Q) has been classified as Likely pathogenic.
Frequency
Consequence
NM_176787.5 missense
Scores
Clinical Significance
Conservation
Publications
- multiple congenital anomalies-hypotonia-seizures syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Orphanet, ClinGen, PanelApp Australia
- Fryns syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PIGN | NM_176787.5 | c.283C>T | p.Arg95Trp | missense_variant | Exon 5 of 31 | ENST00000640252.2 | NP_789744.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PIGN | ENST00000640252.2 | c.283C>T | p.Arg95Trp | missense_variant | Exon 5 of 31 | 1 | NM_176787.5 | ENSP00000492233.1 | ||
| PIGN | ENST00000400334.7 | c.283C>T | p.Arg95Trp | missense_variant | Exon 4 of 30 | 1 | ENSP00000383188.2 | |||
| PIGN | ENST00000638424.1 | n.283C>T | non_coding_transcript_exon_variant | Exon 3 of 29 | 5 | ENSP00000491963.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00 AC: 0AN: 246712 AF XY: 0.00
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1460066Hom.: 0 Cov.: 30 AF XY: 0.0000151 AC XY: 11AN XY: 726192 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Multiple congenital anomalies-hypotonia-seizures syndrome 1 Pathogenic:4
This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 95 of the PIGN protein (p.Arg95Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with an abnormality of the nervous system and/or PIGN-related conditions (PMID: 26633542, 35179230, 35468813). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 378361). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PIGN protein function with a positive predictive value of 80%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
This variant was determined to be likely pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. -
The variant is not observed in the gnomAD v2.1.1 dataset. Predicted Consequence/Location: Protein truncation variants are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.79; 3Cnet: 0.96). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with PIGN related disorder (PMID: 26633542). A different missense change at the same codon (p.Arg95Gln) has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000648403 /PMID: 29096607 /3billion dataset). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. -
- -
not provided Pathogenic:1Uncertain:1
- -
The R95W variant in the PIGN gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The R95W variant was not observed in approximately 6100 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The R95W variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret R95W as a variant of uncertain significance. -
Inborn genetic diseases Pathogenic:1
The c.283C>T (p.R95W) alteration is located in exon 5 (coding exon 2) of the PIGN gene. This alteration results from a C to T substitution at nucleotide position 283, causing the arginine (R) at amino acid position 95 to be replaced by a tryptophan (W). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This variant has been identified in the homozygous state and/or in conjunction with other PIGN variant(s) in individual(s) with features consistent with PIGN-related glycosylphosphatidylinositol deficiency; in at least one instance, the variants were identified in trans (Bayat, 2022; Tian, 2022; Loong, 2023). Other variant(s) at the same codon, c.284G>A (p.R259Q), have been identified in individual(s) with features consistent with PIGN-related glycosylphosphatidylinositol deficiency (Thiffault, 2017; Jalkh, 2019, Duval, 2021). This amino acid position is highly conserved in available vertebrate species. This alteration is predicted to be deleterious by in silico analysis. Based on the available evidence, this alteration is classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at